CURE vs HBTA

Comparison between DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF) and HORIZON EXPEDITION PLUS ETF (HBTA, ETF).

CURE vs HBTA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CURE(ETF)	HBTA(ETF)
Net Assets	$138M	$139M
Expense Ratio	N/A	0.86%
Max Drawdown	69.19%	26.73%
Sharpe Ratio	0.80	1.49
5Y Beta	1.38	1.34
P/E Ratio	28.04	33.62
Forward P/E	17.34	25.10
PEG Ratio	N/A	0.37
5Y Dividends CAGR	63.21%	N/A
5Y EPS CAGR	12.58%	30.19%
Debt to Equity	53.58%	42.05%
P/S Ratio	1.48	4.54
P/B Ratio	4.58	7.35

Net Assets

CURE

$138M

Winner

HBTA

$139M

Expense Ratio

CURE

N/A

HBTA

0.86%

Max Drawdown

CURE

69.19%

Winner

HBTA

26.73%

Sharpe Ratio

CURE

0.80

Winner

HBTA

1.49

5Y Beta

CURE

1.38

Winner

HBTA

1.34

P/E Ratio

Winner

CURE

28.04

HBTA

33.62

Forward P/E

Winner

CURE

17.34

HBTA

25.10

PEG Ratio

CURE

N/A

HBTA

0.37

5Y Dividends CAGR

CURE

63.21%

HBTA

N/A

5Y EPS CAGR

CURE

12.58%

Winner

HBTA

30.19%

Debt to Equity

CURE

53.58%

Winner

HBTA

42.05%

P/S Ratio

Winner

CURE

1.48

HBTA

4.54

P/B Ratio

Winner

CURE

4.58

HBTA

7.35

CURE vs HBTA - Holdings Comparison

CURE and HBTA have 18 common holdings. Overlap is 2.37%

CURE's top 25 holdings weight is 91.92%. HBTA's top 25 holdings weight is 63.15%.

Rank	CURE	HBTA
#1	GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 12.35%	ROUNDHILL MAGNIFICENT SEVEN ETF (MAGS) - 8.83%
#2	ELI LILLY AND CO (LLY) - 11.75%	NVIDIA CORP (NVDA) - 8.36%
#3	DREYFUS GOVT CASH MAN INS (n/a) - 10.69%	ALPHABET INC CLASS A (GOOGL) - 7.74%
#4	JOHNSON & JOHNSON (JNJ) - 7.72%	APPLE INC (AAPL) - 7.10%
#5	GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.02%	BROADCOM INC (AVGO) - 4.43%
#6	ABBVIE INC (ABBV) - 5.24%	AMAZON.COM INC (AMZN) - 3.06%
#7	UNITEDHEALTH GROUP INC (UNH) - 4.75%	TESLA INC (TSLA) - 2.59%
#8	MERCK & CO INC (MRK) - 4.14%	MICRON TECHNOLOGY INC (MU) - 2.11%
#9	AMGEN INC (AMGN) - 2.52%	META PLATFORMS INC CLASS A (META) - 1.94%
#10	THERMO FISHER SCIENTIFIC INC (TMO) - 2.34%	ADVANCED MICRO DEVICES INC (AMD) - 1.71%
#11	GILEAD SCIENCES INC (GILD) - 2.31%	WALMART INC (WMT) - 1.65%
#12	INTUITIVE SURGICAL INC (ISRG) - 2.16%	ELI LILLY AND CO (LLY) - 1.65%
#13	ABBOTT LABORATORIES (ABT) - 2.10%	MICROSOFT CORP (MSFT) - 1.53%
#14	PFIZER INC (PFE) - 2.05%	INTEL CORP (INTC) - 1.17%
#15	BRISTOL-MYERS SQUIBB CO (BMY) - 1.65%	EXXON MOBIL CORP (XOM) - 1.11%
#16	CVS HEALTH CORP (CVS) - 1.61%	CATERPILLAR INC (CAT) - 1.01%
#17	VERTEX PHARMACEUTICALS INC (VRTX) - 1.54%	LAM RESEARCH CORP (LRCX) - 0.92%
#18	DANAHER CORP (DHR) - 1.51%	JOHNSON & JOHNSON (JNJ) - 0.86%
#19	STRYKER CORP (SYK) - 1.50%	APPLIED MATERIALS INC (AMAT) - 0.82%
#20	MEDTRONIC PLC (MDT) - 1.38%	GE AEROSPACE (GE) - 0.81%
#21	MCKESSON CORP (MCK) - 1.29%	n/a (PLTR) - 0.78%
#22	BOSTON SCIENTIFIC CORP (BSX) - 1.19%	THE GOLDMAN SACHS GROUP INC (GS) - 0.76%
#23	ELEVANCE HEALTH INC (ELV) - 1.19%	GE VERNOVA INC (GEV) - 0.74%
#24	THE CIGNA GROUP (CI) - 1.03%	ORACLE CORP (ORCL) - 0.74%
#25	REGENERON PHARMACEUTICALS INC (REGN) - 0.89%	MORGAN STANLEY (MS) - 0.73%
Total Holdings	65	206

CURE vs HBTA - Historical Returns

Returns include dividend reinvestment.

Period	CURE	HBTA
1 month	+14.77%	+1.87%
3 months	-5.02%	+10.85%
6 months	-6.22%	+9.50%
1 year	+34.45%	+33.81%
5 years(CAGR)	+2.34%	N/A
10 years(CAGR)	+12.66%	N/A
Max(CAGR)	+23.14%	+18.32%

Winner

CURE

+14.77%

HBTA

+1.87%

CURE

-5.02%

Winner

HBTA

+10.85%

CURE

-6.22%

Winner

HBTA

+9.50%

Winner

CURE

+34.45%

HBTA

+33.81%

5Y(CAGR)

CURE

+2.34%

HBTA

N/A

10Y(CAGR)

CURE

+12.66%

HBTA

N/A

Max(CAGR)

Winner

CURE

+23.14%

HBTA

+18.32%

CURE vs HBTA - Annual Returns (2011 - 2026)

Returns include dividend reinvestment.

Year	CURE	HBTA
2026	-10.45%	+9.60%
2025	+22.87%	+14.69%
2024	-12.90%	N/A
2023	-8.46%	N/A
2022	-17.91%	N/A
2021	+90.55%	N/A
2020	+4.13%	N/A
2019	+62.36%	N/A
2018	-0.75%	N/A
2017	+62.77%	N/A
2016	-12.42%	N/A
2015	+6.24%	N/A
2014	+83.03%	N/A
2013	+153.15%	N/A
2012	+45.79%	N/A
2011	-9.68%	N/A

CURE vs HBTA Drawdown Comparison

The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.

The maximum drawdown for HBTA was -26.73%, occurring on Apr 8, 2025. Recovery took 93 trading sessions.

The current CURE drawdown is -28.04%. The current HBTA drawdown is -4.50%.

Rank	CURE	HBTA
#1	-69.19% Jan 22, 2020 - Jan 6, 2021	-26.73% Feb 19, 2025 - Jul 3, 2025
#2	-52.25% Apr 8, 2022 - Aug 7, 2025	-13.18% Jan 29, 2026 - Apr 15, 2026
#3	-48.54% Jul 20, 2015 - Jun 22, 2017	-7.03% Oct 29, 2025 - Dec 24, 2025
#4	-44.44% Jul 1, 2011 - Mar 15, 2012	-4.50% Jun 2, 2026 - Jun 5, 2026
#5	-42.27% Oct 1, 2018 - Nov 27, 2019	-3.71% Oct 8, 2025 - Oct 20, 2025
#6	-36.35% Jan 26, 2018 - Sep 13, 2018	-3.55% May 14, 2026 - May 26, 2026
#7	-29.28% Dec 30, 2021 - Apr 8, 2022	-3.48% Jan 12, 2026 - Jan 29, 2026
#8	-22.89% Aug 17, 2021 - Dec 15, 2021	-3.36% Jan 23, 2025 - Feb 14, 2025
#9	-22.59% Sep 24, 2014 - Oct 28, 2014	-2.92% Jul 28, 2025 - Aug 8, 2025
#10	-19.78% Mar 4, 2014 - Jun 19, 2014	-2.46% Aug 14, 2025 - Aug 27, 2025
#11	-19.31% Oct 17, 2012 - Jan 9, 2013	-1.76% Sep 22, 2025 - Oct 6, 2025
#12	-19.31% Jan 20, 2021 - Apr 15, 2021	-1.66% Aug 28, 2025 - Sep 8, 2025
#13	-17.38% Apr 2, 2012 - Jun 29, 2012	-1.60% Jul 3, 2025 - Jul 14, 2025
#14	-15.49% May 28, 2013 - Jul 12, 2013	-1.48% Dec 26, 2025 - Jan 6, 2026
#15	-14.96% Dec 8, 2014 - Jan 22, 2015	-1.05% Apr 17, 2026 - Apr 22, 2026

Correlation

Correlation between CURE and HBTA is 0.17 which considered as a very weak or no correlation - the stocks move independently of each other.

0.17

-101

Dividend Comparison (2011 - 2026)

CURE vs HBTA dividend yield comparison.

Year	CURE	HBTA
2026	0.28%	0.00%
2025	1.12%	0.64%
2024	1.17%	0.00%
2023	2.02%	0.00%
2022	0.38%	0.00%
2021	0.02%	0.00%
2020	0.17%	0.00%
2019	0.40%	0.00%
2018	0.70%	0.00%
2017	0.18%	0.00%
2013	1.24%	0.00%
2012	0.03%	0.00%
2011	2.10%	0.00%